Microbiologists Gear Up To Encourage Better Clinical Laboratory Standards

New federal rules for proficiency testing, personnel, and waived tests worry scientists in clinical laboratories WASHINGTON -- When the 90th annual meeting of the American Society for Microbiology convenes this week in Anaheim, Calif., the talk in the halls will almost certainly be about new federal regulations for clinical laboratories. Those proposed regulations, which implement the Clinical Laboratory Improvement Amendments of 1988, will affect tens of thousands of micro- biologists. The 1

Written byTeresa Herring
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


New federal rules for proficiency testing, personnel, and waived tests worry scientists in clinical laboratories
WASHINGTON -- When the 90th annual meeting of the American Society for Microbiology convenes this week in Anaheim, Calif., the talk in the halls will almost certainly be about new federal regulations for clinical laboratories. Those proposed regulations, which implement the Clinical Laboratory Improvement Amendments of 1988, will affect tens of thousands of micro- biologists.

The 1988 law, known as CLIA 88, remains one of the more hotly contested regulatory issues in the microbiology community. This law revises standards set more than 20 years ago for clinical laboratories. At that time, a complex, book-length set of regulations was developed to assess and maintain those standards, which were based primarily according to whether the laboratories were located in a hospital or here. CLIA 88 shifts the basis for regulation so that the rules are determined by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies